Valuation Amgen Inc. Toronto S.E.

Stocks

Market Closed - Toronto S.E. 15:28:16 2026-10-09 EDT			5-day change	1st Jan Change
30.70 ^CAD	+2.20%		+3.02%	+23.59%

06:25am	Goldman Sachs Adjusts Price Target on Amgen to $475 From $450	MT
10-12	Amgen's Q3 Results Should Reflect Continued Commercial Momentum, BofA Securities Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	225,752	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	28.09%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	267,303	261,649	256,615
Change	-	11.7%	22.4%	-9.42%	17.8%	20.56%	-2.11%	-1.92%
P/E	21.9x	21.7x	23.1x	34.5x	23x	26.5x	23.7x	22.7x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	20.2x	16.4x	13.2x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.5x	2x	5.27x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.79x	5.59x	5.41x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.86x	6.48x	6.15x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	12.3x	11.8x	11.5x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	15.8x	14.7x	13.9x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	24.1x	17.6x	16.4x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	4.16%	5.7%	6.09%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.42%	2.55%	2.66%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.75	17.65	18.41
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	64%	60.4%	60.4%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,969	40,377	41,757
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,769	22,184	22,339
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,944	17,744	18,479
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,540	9,426	9,983
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,551	35,898	30,863
Reference price ²	224.97	262.64	288.02	260.64	327.31	417.57	417.57	417.57
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	540,632	-	-
Announcement Date	2/7/22	1/31/23	2/6/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.65x	12.2x	25.64x	0.58%	1,054B
JOHNSON & JOHNSON	29.26x	6.48x	18.46x	2.02%	636B
ABBVIE INC.	35.78x	8.25x	17.01x	2.47%	497B
MERCK & CO., INC.	111.13x	5.93x	25.32x	2.35%	359B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.12x	5.29x	13.01x	3.01%	273B
ASTRAZENECA PLC	20.57x	4.22x	12.08x	2.1%	246B
AMGEN INC.	26.51x	6.86x	12.28x	2.42%	226B
GILEAD SCIENCES, INC.	-45.64x	6.72x	26.17x	2.19%	187B
Average	27.87x	6.74x	17.97x	2.21%	424.69B
Weighted average by Cap.	33.09x	7.88x	19.51x	1.89%